In this review, we present an overview of recent studies regarding the role of TGF-β in driving LC development and/or metastasis via EMT events, in an attempt to provide a possible framework that can be used in the diagnostic/prognostic and therapeutic approaches against this aggressive cancer. The gene discussed is TGFB1; the disease is cancer.